Drug class
Nitrofuran antibacterial and antiprotozoal agent; monoamine oxidase inhibitor properties
Mechanism of action
After bacterial reduction of its nitro group, reactive intermediates damage microbial DNA and other macromolecules. It also has monoamine oxidase-inhibiting properties that can cause clinically important food and drug interactions.
General use cases
- Historically used for selected bacterial diarrhoeal and protozoal infections, including giardiasis, cholera and dysentery in countries where authorised; use is restricted or discontinued in many jurisdictions and should not be presented as routine contemporary therapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
